Important limitations: Tirzepatide is not indicated for type 1 diabetes or diabetic ketoacidosis and is not recommended for use with other GLP-1 receptor agonists
Clinical Evidence Summary Study Type: Retrospective analysis (not a randomized controlled trial) Participants: 1,131 program completers with BMI 30 Duration: 52-68 weeks Primary Outcome: 19.5% average body weight reduction at 52 weeks Medication: 95.4% compounded semaglutide, 4.6% branded semaglutide Control Group: None Funding/Authors: Ivm Health-affiliated authors (conflict of interest disclosed) Publication: Obesity Pillars , 2025 (PubMed indexed, peer-reviewed) Key Limitation: Self-selected completers
Some soft starts for the day include: Pear kefir smoothie High fiber breakfasts Nausea breakfast ideas Final Thoughts Eating on Wegovy with a sensitive stomach can feel like a moving target, but youre not doing it wrong
Increased Risk of Ineffectiveness: Expired Semaglutide May Not Work Using expired semaglutide can significantly impact its effectiveness, resulting in difficulties in managing blood sugar levels and weight loss
As of recent policy changes, Medicare Part D plans are increasingly permitted to cover FDA-approved weight loss medications, but coverage varies by plan
Advertisement Article continues below this ad For Greg McDermott, weight loss means big gains